Polyclonal Antibody News and Research

RSS
COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells

SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells

Researchers outline characteristics of Omicron variant immune escape and viral entry into host cells

Researchers outline characteristics of Omicron variant immune escape and viral entry into host cells

New tool to help map immune escape with SARS-CoV-2 mutations

New tool to help map immune escape with SARS-CoV-2 mutations

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine

Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine

Antibody validation and rapid peptide mapping technology

Antibody validation and rapid peptide mapping technology

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

A World First: sequencing polyclonal antibodies using only proteomics

A World First: sequencing polyclonal antibodies using only proteomics

SARS-CoV-2 spike mutations during transmission among humans and to animals

SARS-CoV-2 spike mutations during transmission among humans and to animals

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants

The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Urinary shedding of spike protein in COVID-19 patients

Urinary shedding of spike protein in COVID-19 patients